tadamichi
- Losers: Chemours (CC) -35% after reporting FY results.
- Ironwood Pharmaceuticals (NASDAQ:IRWD) -29% after announcing positive topline results from Global Phase III Trial of Once-Weekly Apraglutide in adults with short bowel syndrome with intestinal failure.
- Solowin Holdings (SWIN) -26%.
- WW International (WW) -25% after releasing Q4 results.
- Snowflake (SNOW) -23% after releasing Q4 results.
- Milestone Pharmaceuticals (MIST) -21% on launching stock and warrants offering.
- Envoy Medical (COCH) -19%.
- DoubleVerify Holdings (DV) -18% after releasing Q4 results.
- LivePerson (LPSN) -18% after releasing Q4 results.
- Butterfly Network (BFLY) -17% after releasing Q4 results.
- Figs (FIGS) -15% after releasing Q4 results.
- Schrodinger (SDGR) -14% after releasing Q4 results.
- CommScope Holding Company (COMM) -14% after releasing Q4 results.
- Diversified Energy Company Plc (OTCQX:DEC) -12%.
- Shoals Technologies Group (SHLS) -12% after Q4 results.
- IonQ (IONQ) -12% after Q4 results.
- Incannex Healthcare (IXHL) -11%. after announcing positive topline results from Phase 2 Psi-GAD1 clinical trial of Psilocybin in Generalised Anxiety Disorder.
- Grifols SA ADR (GRFS) -11%.
- SRM Entertainment (SRM) -10%.
- AMC Entertainment Holdings (AMC) -10% after Q4 results.
- ADC Therapeutics SA (ADCT) -9%.
- Infobird Co (IFBD) -9%.
- Kulicke & Soffa (NASDAQ:KLIC) -9%.
- reAlpha Tech (AIRE) -8%.
- Silo Pharma (SILO) -8%.
- Olaplex Holdings (OLPX) -8% after reporting Q4 results.
- Bath & Body Works (BBWI) -8%. after reporting Q4 results.
More on pre-market losers
- Ironwood Pharmaceuticals, Inc. (IRWD) Q4 2023 Earnings Call Transcript
- Kulicke & Soffa Industries, Inc. (KLIC) Q1 2024 Earnings Call Transcript
- Ironwood Pharmaceuticals: Capitalizing On GI Healthcare's Growing Potential
- Ironwood Pharmaceuticals reports mixed Q4 results; initiates FY24 outlook
- Kulicke and Soffa Non-GAAP EPS of $0.30 beats by $0.04, revenue of $171.18M misses by $0.83M